<DOC>
	<DOCNO>NCT00001489</DOCNO>
	<brief_summary>This study design test effect vigabatrin ( gamma-vinyl-GABA ) experimental drug use treatment epilepsy . The study use positron emission tomography ( PET scan ) detect area brain receiving increase blood flow use increased amount glucose . Increases blood flow glucose use good indicator brain activity . Researchers interested determine effect Vigabatrin brain blood flow glucose use .</brief_summary>
	<brief_title>Effect Vigabatrin Brain Blood Flow Glucose Metabolism</brief_title>
	<detailed_description>This double-blind placebo-controlled parallel design protocol investigate effect gamma-vinyl-GABA ( vigabatrin -- GVG ) experimental antiepileptic drug , cerebral glucose metabolism ( LCMRglc ) , blood flow ( CBF ) , seizure frequency , patient uncontrolled complex partial ( CPS ) secondary generalize seizure ( GTCS ) . Positron Emission Tomography ( PET ) use measure CBF LCMRglc .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsy , Complex Partial</mesh_term>
	<mesh_term>Vigabatrin</mesh_term>
	<criteria>Localizationrelated epilepsy . Uncontrolled seizure . Ability tolerate tegretol monotherapy . No systemic illness require drug therapy . No illness might make bad vigabatrin .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 1999</verification_date>
	<keyword>Cerebral Metabolism</keyword>
	<keyword>Complex Partial Seizures</keyword>
	<keyword>Epilepsy</keyword>
</DOC>